View Press Releases
-
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
Jun 16, 2024
-
ProPharma Honored with 2024 CRO Leadership Award
ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.
Jun 12, 2024
-
Huateng Pharma to Exhibit at CPHI China 2024
-
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.
Jun 9, 2024
-
Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics
Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.
Jun 11, 2024
-
Onyx Scientific Aims for European Growth with New BD Hire
Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.
Jun 12, 2024
-
MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer
-
Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).
Jun 11, 2024
-
Integrated DNA Technologies Announces New Primers and Probe Set to Identify H5N1 Avian Influenza
Integrated DNA Technologies today launched the Avian Influenza Type A (H5) Primers and Probe Set to enable researchers to identify, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across bird, environmental, dairy cow, and poultry farm samples.
Jun 10, 2024
-
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials
Jun 11, 2024
-
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
Jun 11, 2024
-
Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.
Jun 10, 2024
-
CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation
-
City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program
Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.
Jun 5, 2024
-
FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning
FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials
Jun 4, 2024
-
Syngene launches platform for rapid, enhanced protein production
-
Sinequa Augments Companies with Release of New Generative AI Assistants
Sinequa announces new AI Assistants; Combining Sinequa’s Search with GenAI provides the ultimate AI Assistant and virtual coworker
Jun 3, 2024
-
The varvis® Software: The First Genomics End-to-End Software Certified as IVDR Class C Device
We are pleased to announce that Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has reached a significant milestone in the field of genetic diagnostics. The varvis® software is now the first complete genomics software solution certified as a Class C device under the In-Vitro Diagnostic Regulation (IVDR) EU 2017/746.
May 31, 2024
-
Qlucore starts project after receiving prestigious EU grant to advance personalized cancer treatment
Qlucore to receive a prestigious EIC Accelerator grant of 2,5 million Euros to accelerate the development of clinical cancer diagnostics solutions for acute myeloid leukemia (AML) as well as bladder cancer.
Jun 2, 2024
-
AES Clean Technology Announces Appointment of New CEO